Filing Flows › Biolife Solutions (BLFS) › Q2 2026
Biolife Solutions (BLFS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Biolife Solutions (BLFS) reported revenue of $28.5M for the second quarter 2026 (Q2 2026), +21% from a year earlier and +4% from the quarter before. Operating margin was 6.0%, net earnings $45.1M (158.4% of revenue).
Biolife Solutions, Q2 2026: revenue $28.5M (+22% year over year), operating margin 6.0%, net earnings $45.1M, operating cash flow $6.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28.5M | +4% | +21% |
| Gross profit | $18.3M | +5% | +20% |
| Operating profit | $1.7M | 63× | — |
| Net earnings | $45.1M | 38× | — |
| Operating cash flow | $6.3M | — | -14% |
| Free cash flow | $5.3M | — | -6% |
What changed
Revenue was $28.5M in Q2 2026, up 21% year over year and up 4% from the previous quarter.
Gross margin was 64.2%, down 0.8 points from Q2 2025. Operating profit was $1.7M, a 6.0% margin (up 74.8 points year over year). Operating expenses fell 47% while revenue rose 21%. The fastest-growing cost line was Research & development (+51%). Net earnings were $45.1M. The tax line was a benefit of $42.4M on pre-tax earnings of $2.8M. Non-operating items added $1.1M, 38% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $6.3M (down 14% year over year), 14% of net earnings. Non-cash charges added back $411K of depreciation and amortization and $3.9M of share-based compensation. Working capital and other items used $43.0M. Capital expenditures of $1.0M left free cash flow of $5.3M.
Questions
What was Biolife Solutions' revenue in the second quarter 2026?
Biolife Solutions (BLFS) reported revenue of $28.5M for the second quarter 2026 (Q2 2026), +21% from a year earlier and +4% from the quarter before.
Was Biolife Solutions profitable in the second quarter 2026?
Operating profit was $1.7M (6.0% of revenue) and net earnings $45.1M.
Source: Biolife Solutions 10-Q on SEC EDGAR.